International Journal of Computer Assisted Radiology and Surgery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2172192, encodeId=1d2b21e21926d, content=审稿速度:6.0 偏重的研究方向：deep learning;medical image processing 经验分享：2023.07.04 提交 至今仍在under review，已经快5个月了。 感觉期刊审稿速度很慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b59090179, createdName=ms4000000155922758, createdTime=Thu Nov 30 19:33:42 CST 2023, time=2023-11-30, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2096169, encodeId=f06d2096169cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：明年4分啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Oct 25 23:57:19 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104356, encodeId=0e971104356a2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104355, encodeId=34e8110435549, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996734, encodeId=2774996e340b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科;计算机 经验分享：审稿速度还是很快的，投稿一个月后大修，3个专家意见都很中肯，修改后，又一次大修，再次修改后，被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=487b2541301, createdName=12520d6fm60(暂无昵称), createdTime=Tue Jul 06 10:33:06 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912147, encodeId=cf1591214ef1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医疗器械 经验分享：文章内容：新型医疗器械解决临床问题，不符合杂志范围，内部转投 2020.12.20 投稿 submitted to Journal 2020.12.27 With Editor 2020.12.29 Transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/874aa80b45a6416d9f73359ea56452ed/a5fffbead6f942eca1b222c821de9362.jpg, createdBy=fad52213464, createdName=MrShepherd, createdTime=Wed Dec 30 13:35:52 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555985, encodeId=7ed45559855d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2018年5月3日投稿，5月11日一审拒稿，效率很高。投的一篇骨科Meta分析，拒稿意见直指本文缺陷，并建议转投临床期刊。个人认为，这本期刊兼具临床实践与技术研发，特别偏向临床的文章不适合投到他这里。个人愚见，仅供参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35d61989719, createdName=飞鸿雪影, createdTime=Fri May 11 20:02:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505559, encodeId=47cd505559f2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：我3月底投出，8月底收到录用通知。个人觉得比较快，一审大概2-3个月，大修，修改一个月，投出去之后二审一个月，然后很快就接收了。杂志对语言要求不算高，文章质量一般就可以了投了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=622f96466, createdName=wjfyunzhu, createdTime=Sun Aug 24 23:29:00 CST 2014, time=2014-08-24, status=1, ipAttribution=)]

2023-11-30 ms4000000155922758 来自荷兰

审稿速度:6.0
偏重的研究方向：deep learning;medical image processing
经验分享：2023.07.04 提交
至今仍在under review，已经快5个月了。
感觉期刊审稿速度很慢。

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2172192, encodeId=1d2b21e21926d, content=审稿速度:6.0 偏重的研究方向：deep learning;medical image processing 经验分享：2023.07.04 提交 至今仍在under review，已经快5个月了。 感觉期刊审稿速度很慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b59090179, createdName=ms4000000155922758, createdTime=Thu Nov 30 19:33:42 CST 2023, time=2023-11-30, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2096169, encodeId=f06d2096169cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：明年4分啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Oct 25 23:57:19 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104356, encodeId=0e971104356a2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104355, encodeId=34e8110435549, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996734, encodeId=2774996e340b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科;计算机 经验分享：审稿速度还是很快的，投稿一个月后大修，3个专家意见都很中肯，修改后，又一次大修，再次修改后，被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=487b2541301, createdName=12520d6fm60(暂无昵称), createdTime=Tue Jul 06 10:33:06 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912147, encodeId=cf1591214ef1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医疗器械 经验分享：文章内容：新型医疗器械解决临床问题，不符合杂志范围，内部转投 2020.12.20 投稿 submitted to Journal 2020.12.27 With Editor 2020.12.29 Transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/874aa80b45a6416d9f73359ea56452ed/a5fffbead6f942eca1b222c821de9362.jpg, createdBy=fad52213464, createdName=MrShepherd, createdTime=Wed Dec 30 13:35:52 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555985, encodeId=7ed45559855d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2018年5月3日投稿，5月11日一审拒稿，效率很高。投的一篇骨科Meta分析，拒稿意见直指本文缺陷，并建议转投临床期刊。个人认为，这本期刊兼具临床实践与技术研发，特别偏向临床的文章不适合投到他这里。个人愚见，仅供参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35d61989719, createdName=飞鸿雪影, createdTime=Fri May 11 20:02:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505559, encodeId=47cd505559f2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：我3月底投出，8月底收到录用通知。个人觉得比较快，一审大概2-3个月，大修，修改一个月，投出去之后二审一个月，然后很快就接收了。杂志对语言要求不算高，文章质量一般就可以了投了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=622f96466, createdName=wjfyunzhu, createdTime=Sun Aug 24 23:29:00 CST 2014, time=2014-08-24, status=1, ipAttribution=)]

2022-10-25 庸医小郝

审稿速度:3.0 | 投稿命中率:50.0
经验分享：明年4分啦

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2172192, encodeId=1d2b21e21926d, content=审稿速度:6.0 偏重的研究方向：deep learning;medical image processing 经验分享：2023.07.04 提交 至今仍在under review，已经快5个月了。 感觉期刊审稿速度很慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b59090179, createdName=ms4000000155922758, createdTime=Thu Nov 30 19:33:42 CST 2023, time=2023-11-30, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2096169, encodeId=f06d2096169cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：明年4分啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Oct 25 23:57:19 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104356, encodeId=0e971104356a2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104355, encodeId=34e8110435549, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996734, encodeId=2774996e340b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科;计算机 经验分享：审稿速度还是很快的，投稿一个月后大修，3个专家意见都很中肯，修改后，又一次大修，再次修改后，被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=487b2541301, createdName=12520d6fm60(暂无昵称), createdTime=Tue Jul 06 10:33:06 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912147, encodeId=cf1591214ef1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医疗器械 经验分享：文章内容：新型医疗器械解决临床问题，不符合杂志范围，内部转投 2020.12.20 投稿 submitted to Journal 2020.12.27 With Editor 2020.12.29 Transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/874aa80b45a6416d9f73359ea56452ed/a5fffbead6f942eca1b222c821de9362.jpg, createdBy=fad52213464, createdName=MrShepherd, createdTime=Wed Dec 30 13:35:52 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555985, encodeId=7ed45559855d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2018年5月3日投稿，5月11日一审拒稿，效率很高。投的一篇骨科Meta分析，拒稿意见直指本文缺陷，并建议转投临床期刊。个人认为，这本期刊兼具临床实践与技术研发，特别偏向临床的文章不适合投到他这里。个人愚见，仅供参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35d61989719, createdName=飞鸿雪影, createdTime=Fri May 11 20:02:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505559, encodeId=47cd505559f2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：我3月底投出，8月底收到录用通知。个人觉得比较快，一审大概2-3个月，大修，修改一个月，投出去之后二审一个月，然后很快就接收了。杂志对语言要求不算高，文章质量一般就可以了投了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=622f96466, createdName=wjfyunzhu, createdTime=Sun Aug 24 23:29:00 CST 2014, time=2014-08-24, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

引言和讨论如何写的不重复？

55 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2172192, encodeId=1d2b21e21926d, content=审稿速度:6.0 偏重的研究方向：deep learning;medical image processing 经验分享：2023.07.04 提交 至今仍在under review，已经快5个月了。 感觉期刊审稿速度很慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b59090179, createdName=ms4000000155922758, createdTime=Thu Nov 30 19:33:42 CST 2023, time=2023-11-30, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2096169, encodeId=f06d2096169cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：明年4分啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Oct 25 23:57:19 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104356, encodeId=0e971104356a2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104355, encodeId=34e8110435549, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996734, encodeId=2774996e340b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科;计算机 经验分享：审稿速度还是很快的，投稿一个月后大修，3个专家意见都很中肯，修改后，又一次大修，再次修改后，被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=487b2541301, createdName=12520d6fm60(暂无昵称), createdTime=Tue Jul 06 10:33:06 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912147, encodeId=cf1591214ef1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医疗器械 经验分享：文章内容：新型医疗器械解决临床问题，不符合杂志范围，内部转投 2020.12.20 投稿 submitted to Journal 2020.12.27 With Editor 2020.12.29 Transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/874aa80b45a6416d9f73359ea56452ed/a5fffbead6f942eca1b222c821de9362.jpg, createdBy=fad52213464, createdName=MrShepherd, createdTime=Wed Dec 30 13:35:52 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555985, encodeId=7ed45559855d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2018年5月3日投稿，5月11日一审拒稿，效率很高。投的一篇骨科Meta分析，拒稿意见直指本文缺陷，并建议转投临床期刊。个人认为，这本期刊兼具临床实践与技术研发，特别偏向临床的文章不适合投到他这里。个人愚见，仅供参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35d61989719, createdName=飞鸿雪影, createdTime=Fri May 11 20:02:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505559, encodeId=47cd505559f2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：我3月底投出，8月底收到录用通知。个人觉得比较快，一审大概2-3个月，大修，修改一个月，投出去之后二审一个月，然后很快就接收了。杂志对语言要求不算高，文章质量一般就可以了投了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=622f96466, createdName=wjfyunzhu, createdTime=Sun Aug 24 23:29:00 CST 2014, time=2014-08-24, status=1, ipAttribution=)]

2021-12-27 Gym璨烨

怎么撰写引言？区别于讨论？

45 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2172192, encodeId=1d2b21e21926d, content=审稿速度:6.0 偏重的研究方向：deep learning;medical image processing 经验分享：2023.07.04 提交 至今仍在under review，已经快5个月了。 感觉期刊审稿速度很慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b59090179, createdName=ms4000000155922758, createdTime=Thu Nov 30 19:33:42 CST 2023, time=2023-11-30, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2096169, encodeId=f06d2096169cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：明年4分啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Oct 25 23:57:19 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104356, encodeId=0e971104356a2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104355, encodeId=34e8110435549, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996734, encodeId=2774996e340b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科;计算机 经验分享：审稿速度还是很快的，投稿一个月后大修，3个专家意见都很中肯，修改后，又一次大修，再次修改后，被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=487b2541301, createdName=12520d6fm60(暂无昵称), createdTime=Tue Jul 06 10:33:06 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912147, encodeId=cf1591214ef1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医疗器械 经验分享：文章内容：新型医疗器械解决临床问题，不符合杂志范围，内部转投 2020.12.20 投稿 submitted to Journal 2020.12.27 With Editor 2020.12.29 Transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/874aa80b45a6416d9f73359ea56452ed/a5fffbead6f942eca1b222c821de9362.jpg, createdBy=fad52213464, createdName=MrShepherd, createdTime=Wed Dec 30 13:35:52 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555985, encodeId=7ed45559855d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2018年5月3日投稿，5月11日一审拒稿，效率很高。投的一篇骨科Meta分析，拒稿意见直指本文缺陷，并建议转投临床期刊。个人认为，这本期刊兼具临床实践与技术研发，特别偏向临床的文章不适合投到他这里。个人愚见，仅供参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35d61989719, createdName=飞鸿雪影, createdTime=Fri May 11 20:02:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505559, encodeId=47cd505559f2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：我3月底投出，8月底收到录用通知。个人觉得比较快，一审大概2-3个月，大修，修改一个月，投出去之后二审一个月，然后很快就接收了。杂志对语言要求不算高，文章质量一般就可以了投了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=622f96466, createdName=wjfyunzhu, createdTime=Sun Aug 24 23:29:00 CST 2014, time=2014-08-24, status=1, ipAttribution=)]

2021-07-06 12520d6fm60(暂无昵称)

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：骨科;计算机
经验分享：审稿速度还是很快的，投稿一个月后大修，3个专家意见都很中肯，修改后，又一次大修，再次修改后，被接收

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2172192, encodeId=1d2b21e21926d, content=审稿速度:6.0 偏重的研究方向：deep learning;medical image processing 经验分享：2023.07.04 提交 至今仍在under review，已经快5个月了。 感觉期刊审稿速度很慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b59090179, createdName=ms4000000155922758, createdTime=Thu Nov 30 19:33:42 CST 2023, time=2023-11-30, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2096169, encodeId=f06d2096169cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：明年4分啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Oct 25 23:57:19 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104356, encodeId=0e971104356a2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104355, encodeId=34e8110435549, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996734, encodeId=2774996e340b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科;计算机 经验分享：审稿速度还是很快的，投稿一个月后大修，3个专家意见都很中肯，修改后，又一次大修，再次修改后，被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=487b2541301, createdName=12520d6fm60(暂无昵称), createdTime=Tue Jul 06 10:33:06 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912147, encodeId=cf1591214ef1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医疗器械 经验分享：文章内容：新型医疗器械解决临床问题，不符合杂志范围，内部转投 2020.12.20 投稿 submitted to Journal 2020.12.27 With Editor 2020.12.29 Transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/874aa80b45a6416d9f73359ea56452ed/a5fffbead6f942eca1b222c821de9362.jpg, createdBy=fad52213464, createdName=MrShepherd, createdTime=Wed Dec 30 13:35:52 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555985, encodeId=7ed45559855d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2018年5月3日投稿，5月11日一审拒稿，效率很高。投的一篇骨科Meta分析，拒稿意见直指本文缺陷，并建议转投临床期刊。个人认为，这本期刊兼具临床实践与技术研发，特别偏向临床的文章不适合投到他这里。个人愚见，仅供参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35d61989719, createdName=飞鸿雪影, createdTime=Fri May 11 20:02:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505559, encodeId=47cd505559f2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：我3月底投出，8月底收到录用通知。个人觉得比较快，一审大概2-3个月，大修，修改一个月，投出去之后二审一个月，然后很快就接收了。杂志对语言要求不算高，文章质量一般就可以了投了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=622f96466, createdName=wjfyunzhu, createdTime=Sun Aug 24 23:29:00 CST 2014, time=2014-08-24, status=1, ipAttribution=)]

2020-12-30 MrShepherd

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：医疗器械
经验分享：文章内容：新型医疗器械解决临床问题，不符合杂志范围，内部转投

2020.12.20 投稿 submitted to Journal
2020.12.27 With Editor
2020.12.29 Transfer

81 0

[GetPortalCommentsPageByObjectIdResponse(id=2172192, encodeId=1d2b21e21926d, content=审稿速度:6.0 偏重的研究方向：deep learning;medical image processing 经验分享：2023.07.04 提交 至今仍在under review，已经快5个月了。 感觉期刊审稿速度很慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b59090179, createdName=ms4000000155922758, createdTime=Thu Nov 30 19:33:42 CST 2023, time=2023-11-30, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2096169, encodeId=f06d2096169cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：明年4分啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Oct 25 23:57:19 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104356, encodeId=0e971104356a2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104355, encodeId=34e8110435549, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996734, encodeId=2774996e340b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科;计算机 经验分享：审稿速度还是很快的，投稿一个月后大修，3个专家意见都很中肯，修改后，又一次大修，再次修改后，被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=487b2541301, createdName=12520d6fm60(暂无昵称), createdTime=Tue Jul 06 10:33:06 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912147, encodeId=cf1591214ef1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医疗器械 经验分享：文章内容：新型医疗器械解决临床问题，不符合杂志范围，内部转投 2020.12.20 投稿 submitted to Journal 2020.12.27 With Editor 2020.12.29 Transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/874aa80b45a6416d9f73359ea56452ed/a5fffbead6f942eca1b222c821de9362.jpg, createdBy=fad52213464, createdName=MrShepherd, createdTime=Wed Dec 30 13:35:52 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555985, encodeId=7ed45559855d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2018年5月3日投稿，5月11日一审拒稿，效率很高。投的一篇骨科Meta分析，拒稿意见直指本文缺陷，并建议转投临床期刊。个人认为，这本期刊兼具临床实践与技术研发，特别偏向临床的文章不适合投到他这里。个人愚见，仅供参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35d61989719, createdName=飞鸿雪影, createdTime=Fri May 11 20:02:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505559, encodeId=47cd505559f2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：我3月底投出，8月底收到录用通知。个人觉得比较快，一审大概2-3个月，大修，修改一个月，投出去之后二审一个月，然后很快就接收了。杂志对语言要求不算高，文章质量一般就可以了投了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=622f96466, createdName=wjfyunzhu, createdTime=Sun Aug 24 23:29:00 CST 2014, time=2014-08-24, status=1, ipAttribution=)]

2018-05-11 飞鸿雪影

审稿速度:1.0 | 投稿命中率:50.0
经验分享：2018年5月3日投稿，5月11日一审拒稿，效率很高。投的一篇骨科Meta分析，拒稿意见直指本文缺陷，并建议转投临床期刊。个人认为，这本期刊兼具临床实践与技术研发，特别偏向临床的文章不适合投到他这里。个人愚见，仅供参考。

285 0

[GetPortalCommentsPageByObjectIdResponse(id=2172192, encodeId=1d2b21e21926d, content=审稿速度:6.0 偏重的研究方向：deep learning;medical image processing 经验分享：2023.07.04 提交 至今仍在under review，已经快5个月了。 感觉期刊审稿速度很慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b59090179, createdName=ms4000000155922758, createdTime=Thu Nov 30 19:33:42 CST 2023, time=2023-11-30, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2096169, encodeId=f06d2096169cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：明年4分啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Oct 25 23:57:19 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104356, encodeId=0e971104356a2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104355, encodeId=34e8110435549, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996734, encodeId=2774996e340b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科;计算机 经验分享：审稿速度还是很快的，投稿一个月后大修，3个专家意见都很中肯，修改后，又一次大修，再次修改后，被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=487b2541301, createdName=12520d6fm60(暂无昵称), createdTime=Tue Jul 06 10:33:06 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912147, encodeId=cf1591214ef1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医疗器械 经验分享：文章内容：新型医疗器械解决临床问题，不符合杂志范围，内部转投 2020.12.20 投稿 submitted to Journal 2020.12.27 With Editor 2020.12.29 Transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/874aa80b45a6416d9f73359ea56452ed/a5fffbead6f942eca1b222c821de9362.jpg, createdBy=fad52213464, createdName=MrShepherd, createdTime=Wed Dec 30 13:35:52 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555985, encodeId=7ed45559855d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2018年5月3日投稿，5月11日一审拒稿，效率很高。投的一篇骨科Meta分析，拒稿意见直指本文缺陷，并建议转投临床期刊。个人认为，这本期刊兼具临床实践与技术研发，特别偏向临床的文章不适合投到他这里。个人愚见，仅供参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35d61989719, createdName=飞鸿雪影, createdTime=Fri May 11 20:02:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505559, encodeId=47cd505559f2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：我3月底投出，8月底收到录用通知。个人觉得比较快，一审大概2-3个月，大修，修改一个月，投出去之后二审一个月，然后很快就接收了。杂志对语言要求不算高，文章质量一般就可以了投了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=622f96466, createdName=wjfyunzhu, createdTime=Sun Aug 24 23:29:00 CST 2014, time=2014-08-24, status=1, ipAttribution=)]

2014-08-24 wjfyunzhu

审稿速度:3.0 | 投稿命中率:75.0
经验分享：我3月底投出，8月底收到录用通知。个人觉得比较快，一审大概2-3个月，大修，修改一个月，投出去之后二审一个月，然后很快就接收了。杂志对语言要求不算高，文章质量一般就可以了投了。

444 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务